Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention | Zendy

Robert Glaubius | Zendy; Urvi M. Parikh | Zendy; Greg Hood | Zendy; Kerri J. Penrose | Zendy; Eran Bendavid | Zendy; John W. Mellors | Zendy; Ume L. Abbas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention

Author(s) -

Robert Glaubius,

Urvi M. Parikh,

Greg Hood,

Kerri J. Penrose,

Eran Bendavid,

John W. Mellors,

Ume L. Abbas

Publication year - 2016

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofw125

Subject(s) - pre exposure prophylaxis , medicine , drug resistance , rilpivirine , human immunodeficiency virus (hiv) , antiretroviral therapy , virology , viral load , men who have sex with men , biology , syphilis , microbiology and biotechnology

Injectable antiretrovirals including non-nucleoside reverse transcriptase inhibitors are being evaluated for pre-exposure prophylaxis for HIV prevention. Mathematical modeling suggests that injectable pre-exposure prophylaxis among KwaZulu-Natal's at-risk populations could have substantial preventive impact but may increase drug resistance unless highly effective.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research